JM 045
Alternative Names: AD20191128; JM-045Latest Information Update: 03 Jan 2023
At a glance
- Originator Jemincare
- Class Antineoplastics; Infertility therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Endometriosis; Female infertility; Precocious puberty; Prostate cancer; Uterine leiomyoma
Most Recent Events
- 22 Dec 2022 Early research in Endometriosis in China (unspecified route) before December 2022 (Jemincare pipeline, December 2022)
- 22 Dec 2022 Early research in Female infertility in China (unspecified route) before December 2022 (Jemincare pipeline, December 2022)
- 22 Dec 2022 Early research in Precocious puberty in China (unspecified route) before December 2022 (Jemincare pipeline, December 2022)